Sign In
to Vote &
Create Storyboards.
 
ImmunoGen Beats Expectations: Gives Strong Guidance For Fiscal 2015 ImmunoGen, Inc. (IMGN) is a biotechnology and medical research firm which develops treatments for cancer using antibody-based therapeutics.
3
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard